Amarin Corp Plc (AMRN)

[sts66]

"From a managed-care perspective, we continue to gain additional Vascepa lives covered in Tier 2 in the third quarter of 2014. Vascepa's now available on formulary to over 200 million lives in the United States, including over 119 million lives in Tier 2 coverage. The continued conversion of lives to Tier 2 status has enabled Amarin to continue to grow Vascepa market share and accelerate new patient starts. And Vascepa Medicare Part D coverage remained strong in spite of generic competitor entrants, with 70% of all Medicare Part D lives covered. We've secured 95% of the existing Tier 2 coverage to 2015

That statement says nothing about Tier levels for Medicare - mine was dropped from T2 in 2014 to T4 in 2015 - if you apply the 95% number to 70% of Medicare, they've only secured 64% on T2 for 2015. Don't know what % of people taking V are on commercial/employer provided plans vs. Medicare though - the ACA continues to put pressure on Part D plans to lower costs through any means necessary, whether it makes financial/medical sense or not - on my plan generic V is only $11 cheaper than V, and as I previously mentioned, once I hit the donut hole my cost/mo will actually go DOWN - does that make any sense in hell?